Millie
your market intelligence analyst
Search Results
18 results
Your search is now limited to «Company News in Infectious Diseases» expert search.
Business Wire 09/20/2019 06:45
About Merck For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases ...
MarketWatch 09/17/2019 06:55
Merck & Co. Inc. said Tuesday the Food and Drug Administration has accepted the biologics license application (BLA) for its V920 investigational vaccine for Ebola Zaire virus. The drugmaker said the FDA also granted priority review for V920. The company said it will base new investigational supply on a combination of leveraging material from production activities at the planned commercial manufacturing site in Germany and new production at a clinical manufacturing site in the U.S. Merck's stock edged up 0.2% in premarket trading. It has gained 7.4% year to date, while the SPDR Health Care Select Sector ETF has tacked on 5.6% and the Dow Jones Industrial Average has advanced 16.1%. Market Pulse Stories are Rapid-fire, short news bursts on st.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities

Sources

Strategic Scenarios

Trends